Inactive Instrument
Sector ratings Caplin Point Laboratories Ltd NSE India S.E.
Stocks
INE475E01018
Pharmaceuticals
|
End-of-day quote
NSE India S.E.
|
||
| - INR | - |
|
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 48.26B | B | |||||||
| 40.5B | A | |||||||
| 11.85B | A | |||||||
| 11.83B | BB | |||||||
| 9.36B | - | |||||||
| 7.5B | A | |||||||
| 7.37B | AA | |||||||
| 7.28B | BB | |||||||
| 5.19B | - | BB | - | - | - | |||
| 4.58B | BB | |||||||
| 4.19B | A | |||||||
| 3.81B | A | |||||||
| 3.59B | - | BB | - | - | - | - | - | |
| 2.87B | CCC | |||||||
| 2.75B | - | B | - | - | - | - | ||
| 2.73B | - | CCC | - | - | - | - | - | |
| 2.56B | B | |||||||
| 2.45B | - | - | - | - | - | |||
| 2.38B | - | - | - | - | - | |||
| Average | 9.53B | BBB | |||||||
| Weighted average by Cap. | BBB |
Select your edition
All financial news and data tailored to specific country editions
